blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1135166

EP1135166 - HAPTEN-CARRIER CONJUGATES FOR TREATING AND PREVENTING NICOTINE ADDICTION [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  07.06.2013
Database last updated on 20.09.2024
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): ES
published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Nabi Biopharmaceuticals
12280 Wilkins Avenue
Rockville, MD 20852 / US
[2003/48]
Former [2001/39]For all designated states
NABI
12280 Wilkins Avenue
Rockville, MD 20852 / US
Inventor(s)01 / ENNIFAR, Sofiane
2210 Bear Valley Terrace
Silver Spring, MD 20906 / US
02 / FATTOM, Ali, Ibrahim
1710 Lorre Drive
Rockville, MD 20852 / US
03 / NASO, Robert, B.
8630 Lochaven Drive
Gaithersburg, MD 20882 / US
 [2001/39]
Representative(s)Pohlman, Sandra M.
df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Theatinerstrasse 16
80333 München / DE
[N/P]
Former [2001/39]Pohlman, Sandra M.
Dörries Frank-Molnia & Pohlman, Triftstrasse 13
80538 München / DE
Application number, filing date99964009.701.12.1999
[2001/39]
WO1999US28272
Priority number, dateUS1998020180001.12.1998         Original published format: US 201800
[2001/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0032239
Date:08.06.2000
Language:EN
[2000/23]
Type: A1 Application with search report 
No.:EP1135166
Date:26.09.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 08.06.2000 takes the place of the publication of the European patent application.
[2001/39]
Type: B1 Patent specification 
No.:EP1135166
Date:13.10.2004
Language:EN
[2004/42]
Type: B9 Corrected patent specification 
No.:EP1135166
Date:02.02.2005
[2005/05]
Search report(s)International search report - published on:EP08.06.2000
ClassificationIPC:A61K47/48, A61K39/385
[2001/39]
CPC:
A61K39/0013 (EP,US); A61K47/50 (KR); A61K47/646 (EP,US);
A61P25/34 (EP); C07K16/44 (EP,US); A61K2039/505 (EP,US);
A61K2039/6037 (EP,US); A61K2039/6068 (EP,US); Y10S435/975 (EP,US);
Y10S436/816 (EP,US); Y10S530/807 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/39]
Extension statesAL05.02.2001
LT05.02.2001
LV05.02.2001
MK05.02.2001
RO05.02.2001
SI05.02.2001
TitleGerman:HAPTEN-TRÄGER-KONJUGATE ZUR BEHANDLUNG UND VORBEUGUNG VON NIKOTINABHÄNGIGKEIT[2001/39]
English:HAPTEN-CARRIER CONJUGATES FOR TREATING AND PREVENTING NICOTINE ADDICTION[2001/39]
French:CONJUGUES HAPTENE-PORTEUR POUR TRAITER ET PREVENIR L'ACCOUTUMANCE A LA NICOTINE[2004/18]
Former [2001/39]TONJUGUES HAPTENE-PORTEUR POUR TRAITER ET PREVENIR L'ACCOUTUMANCE A LA NICOTINE
Entry into regional phase05.03.2001National basic fee paid 
05.03.2001Designation fee(s) paid 
05.03.2001Examination fee paid 
Examination procedure30.06.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
05.03.2001Amendment by applicant (claims and/or description)
05.03.2001Examination requested  [2001/39]
30.10.2003Despatch of a communication from the examining division (Time limit: M04)
05.03.2004Reply to a communication from the examining division
05.04.2004Communication of intention to grant the patent
03.08.2004Fee for grant paid
03.08.2004Fee for publishing/printing paid
Divisional application(s)EP04024278.6  / EP1512414
EP10179154.9  / EP2324855
Opposition(s)Opponent(s)01  13.07.2005  21.07.2005  ADMISSIBLE
Cytos Biotechnology AG
Wagistrasse 25
8952 Schlieren / CH
Opponent's representative
Wichmann, Hendrik, et al, et al
Wuesthoff & Wuesthoff
Patentanwälte und Rechtsanwalt PartG mbB
Schweigerstraße 2
81541 München / DE
 [N/P]
Former [2010/42]
Opponent(s)01  13.07.2005  21.07.2005  ADMISSIBLE
Cytos Biotechnology AG
Wagistrasse 25
8952 Schlieren / CH
Opponent's representative
Wichmann, Hendrik, et al, et al
Wuesthoff & Wuesthoff Schweigstrasse 2
81541 München / DE
Former [2008/38]
Opponent(s)01  13.07.2005  21.07.2005  ADMISSIBLE
Cytos Biotechnology AG
Wagistrasse 25
8952 Schlieren / CH
Opponent's representative
Wichmann, Hendrik, et al, et al
Isenbruck Bösl Hörschler Wichmann Huhn Patentanwälte Prinzregentenstrasse 68
81675 München / DE
Former [2005/36]
Opponent(s)01  13.07.2005  21.07.2005  ADMISSIBLE
Cytos Biotechnology AG
Wagistrasse 25
8952 Schlieren / CH
Opponent's representative
Wichmann, Hendrik, et al, et al
Patentanwälte Isenbruck Bösl Hörschler Wichmann Huhn Postfach 86 08 80
81635 München / DE
22.08.2005Invitation to proprietor to file observations on the notice of opposition
21.12.2005Reply of patent proprietor to notice(s) of opposition
23.04.2008Date of oral proceedings
01.08.2008Despatch of interlocutory decision in opposition
01.08.2008Despatch of minutes of oral proceedings
28.01.2013Legal effect of revocation of patent [ N /P ]
28.01.2013Legal effect of revocation of patent [2013/28]
28.01.2013Despatch of communication that the patent will be revoked
Appeal following opposition01.10.2008Appeal received No.  T1903/08
10.12.2008Statement of grounds filed
28.01.2013Result of appeal procedure: revocation of the patent
30.09.2008Appeal received No.  T1903/08
09.12.2008Statement of grounds filed
28.01.2013Result of appeal procedure: revocation of the patent
28.01.2013Date of oral proceedings
04.02.2013Minutes of the oral proceedings despatched
Fees paidRenewal fee
07.12.2001Renewal fee patent year 03
28.11.2002Renewal fee patent year 04
27.11.2003Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCH13.10.2004
LI13.10.2004
CY01.12.2012
IT01.12.2012
ES02.12.2012
[2020/33]
Former [2014/03]CH13.10.2004
LI13.10.2004
CY01.12.2012
IT01.12.2012
Former [2013/35]CH13.10.2004
LI13.10.2004
CY01.12.2012
Former [2013/33]CH13.10.2004
LI13.10.2004
Former [2007/42]deleted
Former [2007/23]CY01.12.2005
Cited inInternational search[X]WO9203163  (CERNY ERICH H [CH]);
 [Y]WO9323076  (UNIV JOHNS HOPKINS [US]);
 [Y]WO9630049  (IMMULOGIC PHARMA CORP [US]);
 [XY]WO9814216  (IMMULOGIC PHARMA CORP [US]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.